Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 490

1.

Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia.

Cole PD, Beckwith KA, Vijayanathan V, Roychowdhury S, Smith AK, Kamen BA.

Pediatr Neurol. 2009 Jan;40(1):34-41. doi: 10.1016/j.pediatrneurol.2008.09.005.

PMID:
19068252
3.

Negative correlation between cerebrospinal fluid tau protein and cognitive functioning in children with acute lymphoblastic leukemia.

Protas PT, Muszynska-Roslan K, Holownia A, Grabowska A, Wielgat P, Krawczuk-Rybak M, Braszko JJ.

Pediatr Blood Cancer. 2009 Jul;53(1):105-8. doi: 10.1002/pbc.22029.

PMID:
19309718
5.

Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.

Ziereisen F, Dan B, Azzi N, Ferster A, Damry N, Christophe C.

Pediatr Radiol. 2006 Mar;36(3):205-12. Epub 2005 Dec 21.

PMID:
16369780
6.

Level of tau protein in children treated for acute lymphoblastic leukemia.

Muszyńska-Rosłan K, Krawczuk-Rybak M, Protas PT, Hołownia A.

Pediatr Neurol. 2006 May;34(5):367-71.

PMID:
16647996
7.

Cerebrospinal fluid changes in the excitatory amino acids concentration caused by the standard treatment of acute lymphoblastic leukaemia in children do not correlate with their later cognitive functioning.

Protas PT, Muszynska-Roslan K, Holownia A, Grabowska A, Krawczuk-Rybak M, Braszko JJ.

Neuropediatrics. 2009 Dec;40(6):295-7. doi: 10.1055/s-0030-1249655. Epub 2010 May 5.

PMID:
20446226
8.

Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis.

Gavhed D, Akefeldt SO, Osterlundh G, Laurencikas E, Hjorth L, Blennow K, Rosengren L, Henter JI.

Pediatr Blood Cancer. 2009 Dec 15;53(7):1264-70. doi: 10.1002/pbc.22238.

PMID:
19688833
9.

Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.

Vagace JM, Caceres-Marzal C, Jimenez M, Casado MS, de Murillo SG, Gervasini G.

Am J Hematol. 2011 Jan;86(1):98-101. doi: 10.1002/ajh.21897.

10.

White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.

Pääkkö E, Harila-Saari A, Vanionpää L, Himanen S, Pyhtinen J, Lanning M.

Med Pediatr Oncol. 2000 Nov;35(5):456-61.

PMID:
11070477
11.

No role for cerebrospinal fluid myelin basic protein levels in patients treated for childhood acute lymphoblastic leukemia.

Diezi M, Garcia E, Weid Nv, Beck-Popovic M.

J Pediatr Hematol Oncol. 2009 Jun;31(6):393-7. doi: 10.1097/MPH.0b013e31819d1807.

PMID:
19648787
12.

Changes of cerebral biopterin and biogenic amine metabolism in leukemic children receiving 5 g/m2 intravenous methotrexate.

Millot F, Dhondt JL, Mazingue F, Mechinaud F, Ingrand P, Guilhot F.

Pediatr Res. 1995 Feb;37(2):151-4.

PMID:
7537364
13.

Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.

Spiegler BJ, Kennedy K, Maze R, Greenberg ML, Weitzman S, Hitzler JK, Nathan PC.

J Clin Oncol. 2006 Aug 20;24(24):3858-64. Erratum in: J Clin Oncol. 2006 Nov 10;24(32):5181.

14.

Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.

Li Y, Vijayanathan V, Gulinello M, Cole PD.

Pharmacol Biochem Behav. 2010 Jun;95(4):428-33. doi: 10.1016/j.pbb.2010.03.003. Epub 2010 Mar 21.

PMID:
20332001
15.

Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.

Vezmar S, Schüsseler P, Becker A, Bode U, Jaehde U.

Pediatr Blood Cancer. 2009 Jan;52(1):26-32. doi: 10.1002/pbc.21827.

PMID:
19006245
16.

Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.

Fliessbach K, Urbach H, Helmstaedter C, Pels H, Glasmacher A, Kraus JA, Klockgether T, Schmidt-Wolf I, Schlegel U.

Arch Neurol. 2003 Apr;60(4):563-8.

PMID:
12707070
17.

Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study.

Graham ML, Shuster JJ, Kamen BA, Cheo DL, Harrison MP, Leventhal BG, Pullen DJ, Whitehead VM.

Cancer Chemother Pharmacol. 1992;31(3):217-22.

PMID:
1464159
18.

Reversal of CNS-prophylaxis-related leukoencephalopathy after CSF shunting: case histories of identical twins.

Tekkök IH, Carter DA, Robinson MG, Brinker R.

Childs Nerv Syst. 1996 Jun;12(6):309-14.

PMID:
8816294
20.

Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.

Jönsson P, Höglund P, Wiebe T, Schrøder H, Seidel H, Skärby T.

Anticancer Drugs. 2007 Sep;18(8):941-8.

PMID:
17667600
Items per page

Supplemental Content

Write to the Help Desk